Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul-Dec;5(2):134-7.
doi: 10.4103/0259-1162.94751.

Palonosetron and palonosetron plus dexamethasone to prevent postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: A prospective, randomized, double-blind comparative study

Soumyendu Ghosh  1 , Anirban Pal  1 , Amita Acharya  2 , Chaitali Biswas  1 , Tirtha Ratan Ghosh  1 , Subhabrata Ghosh  1
Affiliations

Palonosetron and palonosetron plus dexamethasone to prevent postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: A prospective, randomized, double-blind comparative study

Soumyendu Ghosh et al. Anesth Essays Res. 2011 Jul-Dec.

Abstract

Background: Laparoscopic cholecystectomy (LC) is associated with a high risk of postoperative nausea and vomiting (PONV). Palonosetron is a newer 5HT3 receptor antagonist, which is routinely used in our institution to prevent PONV in patients scheduled for LC, under general anesthesia (GA). We formulated this study to find out whether the palonosetron and dexamethasone combination will be a better choice than palonosetron alone in the prevention of PONV.

Materials and methods: Sixty American Society of Anesthesiologists (ASA) physical status I and II patients, scheduled for LC under GA, were randomized to receive either palonosetron or a combination of palonosetron and dexamethasone. The number of complete responders (no emesis, no requirement of rescue anti-emetic medication) and the four-point nausea score was recorded at 2, 6, 24, 48 h postoperatively and the data was analyzed statistically.

Results: The number of complete responders, as well as the nausea score, did not vary significantly (P=0.718) between the two groups over the 48-h postoperative period.

Conclusions: The palonosetron and dexamethasone combination was not more effective than palonosetron alone in the prevention of PONV, in patients undergoing LC under GA.

Keywords: 5HT3 receptor antagonist; Complete responders; four-point nausea score.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia outcomes are important to avoid.The perspective of patients? Anesth Analg. 1999;89:652–8. - PubMed
    1. Kenny GN. Risk factors for postoperative nausea and vomiting. Anaesthesia. 1994;49:6–10. - PubMed
    1. Bunce KT, Tyers MB. The role of 5 HT in postoperative nausea and vomiting. Br J Anesth. 1992;69(Suppl 1):S60–2. - PubMed
    1. Watcha MF, White PF. Postoperative nausea and vomiting.Its etiology, treatment, and prevention. Anesthesiology. 1992;77:162–84. - PubMed
    1. Stoltz R, Cyong JC, Shah A, Parisi S. Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in US and Japanese healthy subjects. J Clin Pharmacol. 2004;44:520–31. - PubMed